EMA — authorised 14 June 2007
- Marketing authorisation holder: CELEGENE EUROPE BV
- Status: approved
🇪🇺 Revlimid in European Union
EMA authorised Revlimid on 14 June 2007
Marketing authorisation
Revlimid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Revlimid approved in European Union?
Yes. EMA authorised it on 14 June 2007.
Who is the marketing authorisation holder for Revlimid in European Union?
CELEGENE EUROPE BV holds the EU marketing authorisation.